Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes in BRAF+ Melanoma Treated with Vemurafenib
NCT02310451Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vemurafenib in melanoma, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Number of exosomes at Month 12. Started Dec 2014; status: completed.
02
Drugs
vemurafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02310451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310451.